Business Description
Crism Therapeutics Corp
ISIN : VGG042401007
Description
Amur Minerals Corp is a developing mineral exploration company focused on base metal projects in the far east of Russia. The company's principal asset is the Kun-Manie sulphide nickel, copper project located in Amur Oblast, with JORC resources in excess of 1.0 million tonnes of nickel equivalent and a positive independently compiled prefeasiblility study. The company's principal activity is is that of mineral exploration and development of its Kun-Manie project.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | 0.86 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 3/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 11.4 | |||||
| 3-Year EPS without NRI Growth Rate | 13.5 | |||||
| 3-Year FCF Growth Rate | 6.5 | |||||
| 3-Year Book Growth Rate | -48.3 |
Momentum Rank
3/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 22.44 | |||||
| 9-Day RSI | 19.73 | |||||
| 14-Day RSI | 18.67 | |||||
| 12-1 Month Momentum % | -64 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 7.23 | |||||
| Quick Ratio | 7.23 | |||||
| Cash Ratio | 6.62 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -0.3 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -77.16 | |||||
| ROA % | -68.33 | |||||
| ROIC % | -24.45 | |||||
| ROC (Joel Greenblatt) % | -6.96 | |||||
| ROCE % | -17.97 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 0.28 | |||||
| Price-to-Tangible-Book | 0.28 | |||||
| EV-to-EBIT | -0.01 | |||||
| EV-to-EBITDA | -0.01 | |||||
| Price-to-Net-Current-Asset-Value | 0.28 | |||||
| Price-to-Net-Cash | 0.31 | |||||
| Earnings Yield (Greenblatt) % | -10000 | |||||
| FCF Yield % | -63.89 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Crism Therapeutics Corp Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil £) | |||
| EPS (TTM) (£) | -0.874 | ||
| Beta | -0.11 | ||
| Volatility % | 54.08 | ||
| 14-Day RSI | 18.67 | ||
| 14-Day ATR (£) | 0.015179 | ||
| 20-Day SMA (£) | 0.13815 | ||
| 12-1 Month Momentum % | -64 | ||
| 52-Week Range (£) | 0.08 - 0.48 | ||
| Shares Outstanding (Mil) | 32.68 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Crism Therapeutics Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Crism Therapeutics Corp Stock Events
| Event | Date | Price(£) | ||
|---|---|---|---|---|
| No Event Data | ||||
Crism Therapeutics Corp Frequently Asked Questions
What is Crism Therapeutics Corp(LSE:CRTX)'s stock price today?
The current price of LSE:CRTX is £0.11. The 52 week high of LSE:CRTX is £0.48 and 52 week low is £0.08.
When is next earnings date of Crism Therapeutics Corp(LSE:CRTX)?
The next earnings date of Crism Therapeutics Corp(LSE:CRTX) is 2024-09-25 Est..
Does Crism Therapeutics Corp(LSE:CRTX) pay dividends? If so, how much?
Crism Therapeutics Corp(LSE:CRTX) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers